Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852347.RAVU-Zozs8WR71ZaqM0RdyC0yd1Tt_2IoR9FuqokZPnOI130_provenance.
• NP879521.RAdBf5Xdrg7U_Yx38BGxnN9FVvaOL6gtylpiSGDivhw14130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879521.RAdBf5Xdrg7U_Yx38BGxnN9FVvaOL6gtylpiSGDivhw14130_provenance.
• NP271524.RA3gcvlkbvJySacxqZ9-TjBMI_Cffg8_rxZ8zssMPnUBo130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271524.RA3gcvlkbvJySacxqZ9-TjBMI_Cffg8_rxZ8zssMPnUBo130_provenance.
• NP581773.RAe4l5VOcbyU-Opo9lfpjJU0RqORj6GVauoPC-rpSyUBE130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581773.RAe4l5VOcbyU-Opo9lfpjJU0RqORj6GVauoPC-rpSyUBE130_provenance.
• assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP914055.RAD43T8krLrNz7zoJq-aJcMrDYOAz7gY5xfWUn_8ZkmC4130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914055.RAD43T8krLrNz7zoJq-aJcMrDYOAz7gY5xfWUn_8ZkmC4130_provenance.
• NP914057.RAB3Zat5RFFrJW4lDSF8Lo35gVTARDzr1ckfS_6IuMQkI130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914057.RAB3Zat5RFFrJW4lDSF8Lo35gVTARDzr1ckfS_6IuMQkI130_provenance.
• NP222212.RAvt1lmgevfedQ5U-v-KgczhcVt5wq4rNBBpF_efD0TCU130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222212.RAvt1lmgevfedQ5U-v-KgczhcVt5wq4rNBBpF_efD0TCU130_provenance.
• NP914053.RAqBpnaD3zjAhS-1U78HYiMn24Pf9Aqq3QxDlWMjMTLiw130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914053.RAqBpnaD3zjAhS-1U78HYiMn24Pf9Aqq3QxDlWMjMTLiw130_provenance.
• NP269786.RA-8HdICMXqENF6G9Wk3MPOIt9x_d1yOYNYik69nq1sUA130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP269786.RA-8HdICMXqENF6G9Wk3MPOIt9x_d1yOYNYik69nq1sUA130_provenance.
• NP418409.RAIzgveZGhSRfrnTpY2sendxAA81F_ZwErjHMWnJna5JE130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418409.RAIzgveZGhSRfrnTpY2sendxAA81F_ZwErjHMWnJna5JE130_provenance.
• NP421284.RAMhdZ2DsUHhQsQYZ03Ag-s-mc5cHN_rlhO0GRfuy3Zbc130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421284.RAMhdZ2DsUHhQsQYZ03Ag-s-mc5cHN_rlhO0GRfuy3Zbc130_provenance.
• NP543157.RA-TRJ_pdNobE5tCp0PhQmkzDrrFVPMzxtoPcw4KX99EM130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543157.RA-TRJ_pdNobE5tCp0PhQmkzDrrFVPMzxtoPcw4KX99EM130_provenance.
• NP269859.RAK6Mgni3KZE-4M2lRProkRi5VDXExPBFpy6BgoaNbbfs130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP269859.RAK6Mgni3KZE-4M2lRProkRi5VDXExPBFpy6BgoaNbbfs130_provenance.
• NP914054.RAEuygRWx-w1H1EziBRuai7x6uBxW7mdhE76lLugCwI-A130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914054.RAEuygRWx-w1H1EziBRuai7x6uBxW7mdhE76lLugCwI-A130_provenance.
• NP914056.RAHdBdr_Sjwv4e02YJl8O0U2O52ohe7jM9eUOpy7nEy_s130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914056.RAHdBdr_Sjwv4e02YJl8O0U2O52ohe7jM9eUOpy7nEy_s130_provenance.
• NP877887.RAKfZ85RcunabDWKvtCAvld9DI468eUl_gqULqDPg8ZYQ130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877887.RAKfZ85RcunabDWKvtCAvld9DI468eUl_gqULqDPg8ZYQ130_provenance.
• NP914051.RA2AlReFamDODMeY9XYGps-a2fLkF8cZ1NV4iSvzkotdw130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914051.RA2AlReFamDODMeY9XYGps-a2fLkF8cZ1NV4iSvzkotdw130_provenance.
• NP914058.RA8aXHQOi48sX-bx54Nornh3ys45DugaUi_d3rhpUAdhM130_assertion description "[Utilizing a large panel of human GCT tissue samples, we found that AMH type I receptors (ALK2, ALK3 and ALK6) and type II receptor (AMHRII), as well as their downstream effectors Smad1/5, are expressed and active in GCTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914058.RA8aXHQOi48sX-bx54Nornh3ys45DugaUi_d3rhpUAdhM130_provenance.